Sphera Funds Management Ltd. Concert Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $217,000 - $292,000	50,000 Added 5.25%	1,002,783 $5.86 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $1.17 Million - $1.97 Million	273,383 Added 40.24%	952,783 $6.38 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $1.9 Million - $4.32 Million	679,400 New	679,400 $2.86 Million
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $1.87 Million - $5.02 Million	-384,039 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $701,889 - $950,660	74,039 Added 23.88%	384,039 $4.85 Million

Q3 2020 Nov 12, 2020	SELL	$8.67 - $10.82 $3.39 Million - $4.23 Million	-390,710 Reduced 55.76%	310,000 $3.04 Million
Q2 2020 Aug 13, 2020	SELL	$7.8 - $11.52 $2.44 Million - $3.6 Million	-312,329 Reduced 30.83%	700,710 $6.97 Million
Q1 2020 May 14, 2020	BUY	$5.98 - $13.09 $5.22 Million - $11.4 Million	873,039 Added 623.6%	1,013,039 $8.96 Million
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $823,200 - $1.73 Million	140,000 New	140,000 $823,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.